Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria

    ... Three of 4 patients had an improvement in their platelet count, and 3 of 3 had major improvement in abdominal ... with an increase in hemoglobin level and decreased transfusion requirement. CONCLUSIONS: These data indicate that SSAE ...

    Research Article last updated 04/17/2014 - 1:34pm.

  2. PNH - Treatment (OLD)

    ... A blood transfusion is a safe and common procedure. When you receive a transfusion, ... PNH patients are: Red blood cell transfusion Platelet transfusion A transfusion for red blood cells takes 2 to 4 ...

    Topic section last updated 03/10/2016 - 11:09pm.

  3. Therapy for aplastic anemia

    ... registry, including cord blood. He is red cell- and platelet transfusion -dependent. He has been recommended therapy with ...

    Research Article last updated 01/09/2012 - 10:58am.

  4. A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes

    ... patients experiencing bilineage responses. Three of 25 RBC transfusion-dependent (TD) patients achieved transfusion independence (TI) and 5 of 7 platelet TD patients achieved TI. Conclusions: ARRY-614 was well tolerated ...

    Research Article last updated 01/20/2015 - 1:07pm.

  5. Eltrombopag and improved hematopoiesis in refractory aplastic anemia

    ... were clinically significant changes in blood counts or transfusion independence . Patients with a response continued to receive ... minimal toxic effects. Nine patients no longer needed platelet transfusions (median increase in platelet count, 44,000 per cubic ...

    Research Article last updated 07/31/2012 - 2:24pm.

  6. Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

    ... complete remission, hematologic improvement, or RBC or platelet transfusion independence) was 35% in previously treated patients and 73% in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia

    ... × 10(6)/kg). The mean time for neutrophil and platelet recovery was 12.3 and 13.8 days, respectively. Acute GvHD grade I ... no chronic GvHD was documented. All patients were alive and transfusion independent at a median follow-up of 15 months (range: 6-29 ...

    Research Article last updated 07/30/2012 - 1:18pm.

  8. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia-a single-center experience.

    ... The purpose of this study was to observe the outcome of co-transfusion of umbilical cord multipotent stromal cells (UC-MSC) and allogeneic ... rapid engraftment; mean time for neutrophil and platelet recovery was 13.95 d and 20.27 d, respectively. No acute toxicity ...

    Research Article last updated 07/09/2013 - 2:48pm.

  9. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)

    ... of IST; the use of specific hemoglobin and platelet levels as triggers for transfusion support; the use of prophylactic antibiotics; and follow-up ...

    Research Article last updated 12/17/2013 - 8:30am.

  10. Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria

    ... (8%) occurred during the first trimester. Requirements for transfusion of red cells increased during pregnancy, from a mean of 0.14 units ... pregnancy to 0.92 units per month during pregnancy. Platelet transfusions were given in 16 pregnancies. In 54% of pregnancies ...

    Research Article last updated 10/12/2015 - 10:05am.